INTERNATIONAL PATENT: LIPIGON PHARMACEUTICALS AB FILES APPLICATION FOR "ANGPTL4 ASO COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS IN HUMANS"

GENEVA, March 3 -- LIPIGON PHARMACEUTICALS AB (Tvistevagen 48 C907 36 Umea) filed a patent application (PCT/EP2024/073702) for "ANGPTL4 ASO COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS IN HUMANS" on Aug 23, 2024. With publication no. WO/2025/040795, the details related to the patent application was published on Feb 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NILSSON, Stefan K (Triangelgatan 3907 52 Umea), OLIVECRONA, Gunilla (Kungsgatan 21A903 21 Umea), KOOIJMAN, Sander (Obrechtrode 482717 DD Zoetermeer), SCHONKE, Milena (Zaaijerplein 102333 BG Leiden), RENSEN, Patrick C.N (Haarlemm...